BRAIN2BRAIN
DEAD

Serial Number

90843644

Owner

Neuroenhancement Lab, Inc.

Attorney

Steven M Hoffberg

Filing Date

Jul 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

BRAIN2BRAIN Trademark

Serial Number: 90843644

BRAIN2BRAIN is a trademark filed by Neuroenhancement Lab, Inc. on July 22, 2021. The trademark is classified under Class 9 (Computers & Electronics). The application is currently no longer active.

Owner Contact Info

Neuroenhancement Lab, Inc. (3 trademarks)

8 Beaver Dam Road
Pomona, NY 10970

Entity Type: 03

Trademark Details

Filing Date

July 22, 2021

Registration Date

Not Registered

Published for Opposition

September 27, 2022

Goods & Services

Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable medical software for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for analyzing current brain state, storing brainwaves, and modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, accelerating learning, storing brainwaves; Downloadable software for implementing a social network interface; Downloadable scientific and medical data via the Internet; Downloadable Software as a Medical Device (SaMD) for treating insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post-traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Downloadable Software as a Medical Device (SaMD) for use as a medical instrument for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, providing accelerated learning; Recorded medical software for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, providing accelerated learning; Recorded Software as a Medical Device (SaMD) for treating insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for analyzing current brain state, storing brainwaves, and modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, providing accelerated learning

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Dec 22, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Dec 22, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2025 EXRA
SOU EXTENSION 5 GRANTED
Oct 6, 2025 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 6, 2025 AITU
SOU TEAS EXTENSION RECEIVED
May 22, 2025 EEXT
SOU EXTENSION 5 FILED
May 21, 2025 EXT5
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 3, 2025 EXRA
SOU EXTENSION 4 GRANTED
Nov 23, 2024 EX4G
SOU EXTENSION 4 FILED
Nov 23, 2024 EXT4
SOU TEAS EXTENSION RECEIVED
Nov 22, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 23, 2024 EXRA
SOU EXTENSION 3 GRANTED
May 22, 2024 EX3G
SOU EXTENSION 3 FILED
May 22, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
May 22, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 24, 2023 EXRA
SOU EXTENSION 2 GRANTED
Nov 22, 2023 EX2G
SOU EXTENSION 2 FILED
Nov 22, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Nov 22, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 24, 2023 EXRA
SOU EXTENSION 1 GRANTED
May 22, 2023 EX1G
SOU EXTENSION 1 FILED
May 22, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
May 22, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 23, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2022 TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 11, 2022 GNRN
NON-FINAL ACTION E-MAILED
Apr 11, 2022 GNRT
NON-FINAL ACTION WRITTEN
Apr 11, 2022 CNRT
REMOVED FROM TEAS PLUS
Apr 11, 2022 RFTP
ASSIGNED TO EXAMINER
Mar 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 23, 2021 NWOS
NEW APPLICATION ENTERED
Jul 26, 2021 NWAP